Target intelligence / Profile preview

Carotid atherosclerotic plaque

Molecular classification
Other
01

Overview

Carotid atherosclerotic plaque is a pathological accumulation of lipids, inflammatory cells, and connective tissue within the carotid artery wall, resulting in narrowing of the arterial lumen. Plaque formation impedes cerebral blood flow and, if ruptured, may induce ischemic stroke by embolization of plaque fragments. Plaques are characterized by a lipid-rich necrotic core covered by a fibrous cap, surrounded by infiltrating immune cells and occasional calcification. Severity is monitored by imaging modalities (ultrasound, MRI) assessing features such as plaque area, echogenicity, and lumen narrowing. Statins stabilize plaque by reducing lipid content and inflammation. Surgical interventions (endarterectomy, stenting) physically remove or bypass plaque to restore blood flow and decrease stroke risk[1][2][3][4][5].

Other names
Carotid plaquecarotid artery plaquearterial plaqueatherosclerotic plaque of the carotid arterycarotid stenosis
02

Mechanism of action

Statins: decrease LDL-cholesterol and stabilize plaque (anti-inflammatory, lipid-lowering, increases plaque calcification and echogenicity) [2] Antiplatelet agents: reduce thrombotic risk by inhibiting platelet aggregation Antihypertensives: lower blood pressure and decrease hydrodynamic contribution to plaque progression

03

Biological functions

Other (not a singular molecule or receptor; pathological accumulation of proteins, lipids, and cells leads to arterial narrowing)
04

Disease associations

Cardiovascular diseasestrokeinflammation
05

Safety considerations

Risk of plaque rupture leading to stroke [1][5]Perioperative risk of stroke with carotid interventions [4]Potential for embolization during carotid stenting procedures [4]Statins generally safe, but aggressive therapy perioperatively not always more beneficial [2][4]
06

Interacting drugs

Statins (atorvastatin, rosuvastatin, pitavastatin, pravastatin)

2 more in the full profile.

07

Biomarkers

Carotid intima–media thickness (cIMT) for cardiovascular risk [3]Lumen diameter by imaging [3]High-sensitivity C-reactive protein (hs-CRP) indicating inflammation [2]Imaging phenotypes (MRI plaque lipid core size, plaque echogenicity, neovascularization on ultrasound) [2][3]

Beyond the preview

Go deeper on Carotid atherosclerotic plaque.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carotid atherosclerotic plaque.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call